RE:RE:RE:RE:Companies now seek to moderate TME to expand PD-(L)1 effectOne last question to myself. As a biomarker in PDAC I think a low expression of CEACAM6 is indicated. If so, if CEACAM6 can be downregulated, I think that is the correct term, would not said biomarker have a dual purpose. Those who would likely benefit, and those who might benefit if the expression could be lowered.
Please advise if you know if CEACAM6 expression can be lowered. TIA